Last update 21 Nov 2024
C-4-29
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Autologous CAR-T |
Synonyms |
Target |
Mechanism BCMA inhibitors(B-cell maturation protein inhibitors), CD70 inhibitors(CD70 antigen inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with C-4-29嵌合抗原受体T淋巴细胞（C-4-29）细胞制剂治疗复发/难治性多发性骨髓瘤的I期临床研究
[Translation] Phase I clinical study of chimeric antigen receptor T lymphocyte (C-4-29) cell preparations in the treatment of relapsed/refractory multiple myeloma
Phase I Clinical Study of CAR-T Cells (C-4-29) in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma
100 Clinical Results associated with C-4-29
Login to view more data
100 Translational Medicine associated with C-4-29
Login to view more data
100 Patents (Medical) associated with C-4-29
Login to view more data
100 Deals associated with C-4-29
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Renal Cell Carcinoma | Phase 1 | CN | 22 Aug 2022 | |
| Plasma cell myeloma refractory | Phase 1 | CN | 16 Jun 2021 | |
| Relapse multiple myeloma | Phase 1 | CN | 16 Jun 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free